Last week at the 23andMe headquarters, over 100 researchers gathered together for the company’s annual Genome Research Day.
Data is at the heart of applicable genomics. As the volume and depth of genomic data grows, bioinformaticians are translating the data into interpretable patterns leading to new biological insight.
Our ability to reconstruct physical features from DNA is advancing, but can we ensure the privacy of “anonymised” genetic data if we can predict the face of its owner?
The U.K. Prime Minister, Theresa May has made her first appearance in a series on industrial strategy, whereby she has pledged millions of pounds of government funding to develop artificial intelligence to transform outcomes through early diagnosis of cancer and chronic disease.
Researchers at Oregon State University have developed a great new RNA annotation tool.
A new way to simplify complex biomolecular data about tumours could in principle make it easier to prescribe the appropriate treatment for a specific patient.
Illumina has revealed that it has acquired Edico Genome, with the intention of building on the solid foundation of DRAGEN, to deliver a more streamlines sample for customers.
A bit of advice for any criminals inspired to try and edit their own genes – it’s unlikely to work, and it may present health risks.
There are fears that CRISPR could be used by criminals to clear their names from forensic databases or evade detection, as access to the technique becomes more widely available.
Much of medicine is about information — the data that helps doctors make the right choices about our treatment. So how will the revolution in big data impact complex healthcare systems like the NHS?
Cryptographic system could enable ‘crowdsourced’ genomics, with volunteers contributing information to privacy-protected databases.